News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website


Clinical Trial Results Reported at ASCO on the Use of Celgene`s THALOMID(R) (Thalidomide) for the Treatment of Renal Cell Carcinoma and Glioblastoma (PR Newswire)...This study evaluated patient response rate and tumor perfusion changes for a median of three cycles (1 cycle = 28 days) of treatment.......About Glioblastoma Multiforme Glioblastoma multiforme is the most aggressive form of the primary brain tumors known collectively as gliomas....- May 16 7:30 AM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557